Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001127602-22-026333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-23 | 2022-11-21 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $9.65 | +10.0K | 416.1K | +2% | +$96.5K |
| D | 2022-11-23 | 2022-11-21 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $40.89 | -10.0K | 406.1K | -2% | -$408.9K |
| D | 2022-11-23 | 2022-11-21 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $0.00 | -10.0K | 175.7K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | M | A | 10,000 | $9.65 | 416,089 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-21 | S | D | 10,000 | $40.89 | 406,089 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-11-21 | M | D | 10,000 | $0.00 | 175,691 | D | $9.65 · 2014-03-24 to 2024-02-24 | 10,000 Common Stock |